H.R. 3674 118th Congress
Providing Relief and Stability for Medicare Patients Act of 2023
- Health
- Sponsor: Rep. Bilirakis, Gus M. [R-FL-12]
- Congress.gov ↗
Latest action, Dec 17, 2024: Referred to the Subcommittee on Health.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
17 cosponsors
Sponsored by Rep. Bilirakis, Gus M. [R-FL-12] (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
7 D · 10 R
Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
7 reports
7 reports
ABBOTT (CVC) (FKA CARDIOVASCULAR SYSTEMS, INC, CARDIOVASCULAR COALITION)
LIBERTY PARTNERS GROUP, LLC
6 reports
ABBOTT FKA CSI (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA)
LIBERTY PARTNERS GROUP, LLC
6 reports
ALLIANCE FOR PHYSICAL THERAPY QUALITY AND INNOVATION (OBFA FKA USPA)
LIBERTY PARTNERS GROUP, LLC
6 reports
AMERICAN COLLEGE OF RADIATION ONCOLOGY
LIBERTY PARTNERS GROUP, LLC
6 reports
AMERICAN VASCULAR ACCESS, LLC (CARDIOVASCULAR COALITION)
LIBERTY PARTNERS GROUP, LLC
6 reports
AMERICAN VASCULAR ASSOCIATES (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA)
LIBERTY PARTNERS GROUP, LLC
6 reports
AMERICAN VEIN & LYMPHATIC SOCIETY (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA)
LIBERTY PARTNERS GROUP, LLC
6 reports
ARISE VASCULAR (CARDIOVASCULAR COALITION)
LIBERTY PARTNERS GROUP, LLC
6 reports
ARIZONA KIDNEY DISEASE AND HYPERTENSION CENTER (DIALYSIS VASCULAR ACCESS COALITI
LIBERTY PARTNERS GROUP, LLC
6 reports
AUSTIN KIDNEY ASSOCIATES (DVAC REF)
LIBERTY PARTNERS GROUP, LLC
6 reports
AZURA VASCULAR CARE (FKA FRESENIUS VASCULAR CARE) (CARDIOVASCULAR COALITION)
LIBERTY PARTNERS GROUP, LLC
6 reports
All 25 of 46 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 7 | $5.0M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN COLLEGE OF CARDIOLOGY | 7 | $3.3M | Q4 2023 | Q3 2024 | yes | |
| SOCIETY FOR VASCULAR SURGERY | 7 | $610K | Q4 2023 | Q3 2024 | yes | |
| ABBOTT (CVC) (FKA CARDIOVASCULAR SYSTEMS, INC, CARDIOVASCULAR COALITION) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| ABBOTT FKA CSI (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| ALLIANCE FOR PHYSICAL THERAPY QUALITY AND INNOVATION (OBFA FKA USPA) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| AMERICAN COLLEGE OF RADIATION ONCOLOGY | LIBERTY PARTNERS GROUP, LLC | 6 | $120K | Q4 2023 | Q3 2024 | yes |
| AMERICAN SOCIETY FOR RADIATION ONCOLOGY | 6 | $1.1M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN VASCULAR ACCESS, LLC (CARDIOVASCULAR COALITION) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| AMERICAN VASCULAR ASSOCIATES (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| AMERICAN VEIN & LYMPHATIC SOCIETY (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| ARISE VASCULAR (CARDIOVASCULAR COALITION) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| ARIZONA KIDNEY DISEASE AND HYPERTENSION CENTER (DIALYSIS VASCULAR ACCESS COALITI | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| AUSTIN KIDNEY ASSOCIATES (DVAC REF) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| AZURA VASCULAR CARE (FKA FRESENIUS VASCULAR CARE) (CARDIOVASCULAR COALITION) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| AZURA VASCULAR CARE (FKA FRESENIUS VASCULAR)(DIALYSIS VASCULAR ACCESS COALITION) | LIBERTY PARTNERS GROUP, LLC | 6 | $60K | Q4 2023 | Q3 2024 | yes |
| AZURA VASCULAR CARE (OBFA) FKA AZURA VASCULAR CARE-NCP (OBFA FKA USPA) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| BALBOA NEPHROLOGY MEDICAL GROUP (DVAC REF) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| BOSTON SCIENTIFIC (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| CARDIOVASCULAR COALITION | LIBERTY PARTNERS GROUP, LLC | 6 | $640K | Q4 2023 | Q3 2024 | yes |
| CARDIOVASCULAR INSTITUTE OF THE SOUTH (CARDIOVASCULAR COALITION) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| DALLAS NEPHROLOGY ASSOCIATES (DVAC REF) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| LIFELINE VASCULAR CARE (FKA ACCESS) (DIALYSIS VASCULAR ACCESS COALITION) | LIBERTY PARTNERS GROUP, LLC | 6 | $60K | Q4 2023 | Q3 2024 | yes |
| LIFELINE VASCULAR CARE (FKA LIFELINE VASCULAR ACCESS) (CARDIOVASCULAR COALITION) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| MEDTRONIC (CARDIOVASCULAR COALITION) | LIBERTY PARTNERS GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |